<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-27T23:41:43Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/12129" metadataPrefix="ese">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/12129</identifier><datestamp>2026-09-24T00:05:37Z</datestamp><setSpec>com_10259_11209</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_11210</setSpec></header><metadata><europeana:record xmlns:europeana="http://www.europeana.eu/schemas/ese/" xmlns:confman="org.dspace.core.ConfigurationManager" xmlns:doc="http://www.lyncode.com/xoai" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.europeana.eu/schemas/ese/ http://www.europeana.eu/schemas/ese/ESE-V3.4.xsd">
<dc:title>Impact of a short-term nitrate and citrulline co-supplementation on sport performance in elite rowers: a randomized, double-blind, placebo-controlled crossover trial</dc:title>
<dc:creator>Viribay, Aitor</dc:creator>
<dc:creator>Alcantara, Juan M. A.</dc:creator>
<dc:creator>López, Iker</dc:creator>
<dc:creator>Mielgo Ayuso, Juan</dc:creator>
<dc:creator>Castañeda Babarro, Arkaitz</dc:creator>
<dc:subject>Physiology</dc:subject>
<dc:subject>Oxide nitric</dc:subject>
<dc:subject>Supplementation</dc:subject>
<dc:subject>Metabolism</dc:subject>
<dc:subject>Fisiología del ejercicio</dc:subject>
<dc:subject>Sports--Physiological aspects</dc:subject>
<dc:description>Purpose Citrulline (CIT) and beetroot extract (BR) have separately shown benefits in rowing performance-related outcomes.&#xd;
However, effects of combined supplementation remain to be elucidated. The main purpose of this research was to study the&#xd;
effects of 1 week of daily co-supplementation of 3.5 g BR (500 mg NO3&#xd;
−) plus 6 g CIT on aerobic performance, maximal&#xd;
strength, and high-intensity power and peak stroke in elite male rowers compared to a placebo and to a BR supplementation.&#xd;
Methods 20 elite rowers participated in this randomized, double-blind, placebo-controlled crossover trial completing 1 week&#xd;
of supplementation in each group of study: Placebo group (PLAG); BR group (BRG); and BR + CIT group (BR-CITG).&#xd;
3 main physical tests were performed: aerobic performance, Wingate test and CMJ jump, and metabolic biomarkers and&#xd;
physiological outcomes were collected.&#xd;
Results The Wingate all-out test showed no between-condition differences in peak power, mean power, relative power, or&#xd;
fatigue index (P > 0.05), but clearance of lactate was better in BR-CITG (P &lt; 0.05). In the performance test, peak power&#xd;
differed only between PLAG and BR-CITG (P = 0.036), while VO2peak and maximum heart rate remained similar. CMJ&#xd;
jumping test results showed no between-condition differences, and blood samples were consistent (P > 0.200).&#xd;
Conclusion Supplementation with 3.5 g of BR extract plus 6 g of CIT for 7 days improved lactate clearance after Wingate&#xd;
test and peak power in a performance test. No further improvements were found, suggesting longer period of supplementation&#xd;
might be needed to show greater benefits.</dc:description>
<dc:date>2026-09-23T08:47:12Z</dc:date>
<dc:date>2026-09-23T08:47:12Z</dc:date>
<dc:date>2024-02</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:identifier>1439-6319</dc:identifier>
<dc:identifier>https://hdl.handle.net/10259/12129</dc:identifier>
<dc:identifier>10.1007/S00421-024-05415-4</dc:identifier>
<dc:identifier>1439-6327</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>European Journal of Applied Physiology. 2024, V. 124, n. 6, p.  1911-1923</dc:relation>
<dc:relation>https://doi.org/10.1007/s00421-024-05415-4</dc:relation>
<dc:rights>Atribución 4.0 Internacional</dc:rights>
<dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:format>application/pdf</dc:format>
<dc:publisher>Springer Nature</dc:publisher>
<europeana:object>https://riubu.ubu.es/bitstream/10259/12129/4/Viribay-ejap_2024.pdf.jpg</europeana:object>
<europeana:provider>Hispana</europeana:provider>
<europeana:type>TEXT</europeana:type>
<europeana:rights>http://creativecommons.org/licenses/by/4.0/</europeana:rights>
<europeana:dataProvider>RIUBU. Repositorio Institucional de la Universidad de Burgos</europeana:dataProvider>
<europeana:isShownAt>https://hdl.handle.net/10259/12129</europeana:isShownAt>
</europeana:record></metadata></record></GetRecord></OAI-PMH>